In-Vitro Fertilization Market Future Trends and Scope Analysis by 2024

The Report in light of Global In-Vitro Fertilization Market is the latest extension to the database of Infinium Global Research. This exploration investigates in light of uses, advancement, geology, and sorts. The Report gives a clear Global In-Vitro Fertilization Market audit nearby the examination of industry’s gross edge, cost structure, usage esteem, and deal cost. The principle partnership of the In-Vitro Fertilization Market, makers, and dealers are profiled in the report close by the latest Industry change present and future examples.  The report also deep dives into the sub-segments of In-Vitro Fertilization Market by instrument (filters, pressure pumps, valves, emitters and drip tube), technology (fruits & vegetables, cereals & pulses, turf & ornamentals and oilseeds & pulses), end-user (hospitals, fertility clinics and cryobanks) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW.

The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the In-Vitro Fertilization Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global In-Vitro Fertilization Market are Cook Medical Inc., Hamilton Thorne, Inc., Laboratoire CCD, Nidacon International AB, Thermo Fisher Scientific Inc., Coopersurgical Inc., Irvine Scientific, Merck KGaA, Nikon Corporation and Vitrolife AB.

Improving health care infrastructure to drive the growth in the market

Improving health care infrastructure and favorable healthcare cost are driving the growth of the market. Further, the market growth is attributed by the reduced conceiving rates mainly in women aged 40 years or more, ovulation disorder, damaged or blocked fallopian tube, premature ovarian failure, impaired sperm production or function and unexplained infertility are the factors, further leading to the market growth. Growing number of men and women who are focusing on their career are freezing their eggs/sperms to have the child some years later. Further government funding to encourage egg/sperm freezing and provide with a chances of multiple pregnancies, technological advancements that allow analysis of the genetic disorder, and various industrial revolutions are expected to boom the market growth. Additionally, delay in pregnancies in many cases leads to pregnancy-associated complications and increase the chance of infertility thus, results in the adoption of in-vitro fertilization which boost the market growth. However, on the flip side high cost involved in in-vitro fertilization may hamper the growth of this market.

Asia Pacific region to dominate the global In-Vitro Fertilization market through 2018-2024

Asia Pacific region accounts for the largest market share of the in-vitro fertilization market followed by Europe. In Asia Pacific region factors such as an increase in the median age of the first time motherhood, rising prevalence of PCOS, growth in fertility tourism, increasing infertility rates and government initiatives are driving the growth of in-vitro fertilization market in this region. Further, in Europe region, growing demand for the fertility treatment is boosting the growth in this market.

CombiMatrix Corporation launched Combi PGD, a diagnostic technique used prior to embryo implantation

In April 2016, CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic screening services, had launched CombiPGD™ – Preimplantation Genetic Diagnosis (PGD) for single gene disorders and chromosomal translocations.  CombiPGD is a test performed prior to embryo implantation to help identify genetic defects created through in vitro fertilization to prevent certain diseases or disorders from being passed on to the child.

Assisted reproductive technology is typically associated with infertility. However, some fertile couples whose children are at risk for a specific genetic disease or hereditary chromosomal abnormality choose to undergo in vitro fertilization in order to perform PGD. CombiMatrix offered CombiPGS™, which is a test that may help decrease the rate of implantation failure and miscarriage by allowing physicians to identify and transfer chromosomally normal embryos.

Browse Detailed TOC, Description and Company Mentioned in this Premium Report@ 

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global in-vitro fertilization market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of in-vitro fertilization market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the in-vitro fertilization market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the in-vitro fertilization market to understand the present and future trends in this market and formulate their strategies accordingly.

Reset Password